Back to the main directory
EarningsReview / Equity
- FQ1''23 postview: mixed, but key indicators positive. by BNP Paribas Exane
- ZTO Express (ZTO US) by HSBC
- Bye Bye Birdie by BNP Paribas Exane
- Sun Art Retail Group (6808 HK) by HSBC
- Is it finally time to buy BT? and Q''s for Management by BNP Paribas Exane
- Star Bulk Minor model adjustments by DnB Markets
- StoneCo (STNE US) by HSBC
- 2023 saved by ICAPS by BNP Paribas Exane
- Fuel to the Fire by BNP Paribas Exane
- Batteries and boxes by BNP Paribas Exane
- Lerøy Seafood - Meagre salmon carrying a high cost base by Danske Bank Equity Research
- B2Holding - Buy/NOK 11.10 (12.30): In a good position by Nordea
- Infotel - Croissance exceptionnelle en Logiciels by MidCap Partners
- Addtech - Buy/SEK 246 (220): Proving its superiority by Nordea
- Infotel - Exceptional Growth in Software by MidCap Partners
- INVEST SECURITIES - MRM : Un T1 2023 satisfaisant en particulier grâce à l'indexation - NEUTRE vs ACHAT, OC 25,1€ (vs 29,2€) by Invest Securities
- WOOD Daily: KazMunayGas (BUY - initiation of coverage), ELPE GA, KRKG SV, GPW PW, DOM PW, BFT PW, DAT PW, STH PW, TGN RO by Wood and Company
- COLONIAL: RDOS. 1T’23 (ANÁLISIS BANCO SABADELL) by Sabadell
- A Glass Half-Full by BNP Paribas Exane
- Weekly prescription tracker by BNP Paribas Exane
- EQS Group - Catching the whistleblowing wave by Edison Investment Research
- ENAV - 1Q23 IN LINE, STRONG TRAFFIC DRIVING FY23 GUIDANCE UPGRADE by Equita Sim
- Zomato (ZOMATO IN) by HSBC
- Philippines Banks by HSBC
- Genmab (Sell, TP: DKK2650.00) - FDA approval of epcoritamab by DnB Markets